590 related articles for article (PubMed ID: 1666046)
21. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
22. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
23. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
Liu-Chen LY; Li SX; Rohrbach KW; Lewis ME
Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
[No Abstract] [Full Text] [Related]
24. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
25. The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse.
Suh HW; Lim JS; Song DK; Kim YH; Tseng LF
Neuropeptides; 1994 Aug; 27(2):143-9. PubMed ID: 7991069
[TBL] [Abstract][Full Text] [Related]
26. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
27. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
[TBL] [Abstract][Full Text] [Related]
28. Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).
Ward SJ; Fries DS; Larson DL; Portoghese PS; Takemori AE
Eur J Pharmacol; 1985 Jan; 107(3):323-30. PubMed ID: 2984010
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of the opioid receptor complex by the chronic administration of morphine: a biochemical marker related to the development of tolerance and dependence.
Rothman RB; Long JB; Bykov V; Xu H; Jacobson AE; Rice KC; Holaday JW
Peptides; 1991; 12(1):151-60. PubMed ID: 1646998
[TBL] [Abstract][Full Text] [Related]
30. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
[TBL] [Abstract][Full Text] [Related]
31. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
[TBL] [Abstract][Full Text] [Related]
32. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
[TBL] [Abstract][Full Text] [Related]
35. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
Qi JA; Mosberg HI; Porreca F
Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
[TBL] [Abstract][Full Text] [Related]
36. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
Heyman JS; Mosberg HI; Porreca F
NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
[TBL] [Abstract][Full Text] [Related]
37. The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site.
Cotton R; Kosterlitz HW; Paterson SJ; Rance MJ; Traynor JR
Br J Pharmacol; 1985 Apr; 84(4):927-32. PubMed ID: 2988685
[TBL] [Abstract][Full Text] [Related]
38. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
Calcagnetti DJ; Holtzman SG
Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
[TBL] [Abstract][Full Text] [Related]
39. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
40. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
Sbacchi M; La Regina A; Petrillo P; Tavani A
NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
